NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with Irish Pharmacist includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.

ADVERTISMENT

ADVERTISMENT

HPRA interrupts supply of fake Covid-19 tests targeted at Irish consumers and businesses

By Irish Pharmacist - 25th Jun 2021

Close-up view of covid-19 IgG/IgM rapid test casette indicating a negative infection .

Potentially counterfeit Covid-19 tests have been offered for sale to Irish individuals and businesses, the Health Products Regulatory Authority (HPRA) has confirmed. A spokesperson for the Authority said a “small number” of such instances had occurred to date, but that the supply was successfully “interrupted” through the co-operation of would-be purchasers.

“The HPRA is aware of a small number of instances where potentially falsified Covid-19 tests have been offered to individuals/entities in Ireland and with their co-operation, this supply has been interrupted,” said the spokesperson.

“Should the public have concerns in relation to potentially falsified tests available in Ireland, they are encouraged to report the issue to the HPRA via email at devices@hpra.ie or enforcementcontrol@hpra.ie.”

The HPRA monitors medical devices placed on the Irish market and conducts inspections at medical device manufacturing facilities. It also monitors the market for potentially falsified medical devices, including in vitro diagnostic tests related to Covid-19. Last year, the HPRA detained 1.6 million units of illegal medicines, an increase of 58 per cent on 2019 (see feature, p8).

Among these were more than 56,000 units of Covid-19 medicines, the majority of which related to traditional Chinese medicine not approved or authorised for use in Ireland. Meanwhile, the Authority said the supply of medicines has not been “significantly” affected by Brexit and is unlikely to be in the future based on comparisons of drug shortage data for 2020 and 2021.

“This is reflected in the number of medicines shortages that have been notified to the HPRA in the first five months of 2021, which is fully consistent with previous years,” said the spokesperson.

ADVERTISMENT

Latest

ADVERTISMENT

ADVERTISMENT

ADVERTISMENT

Latest Issue

Irish Pharmacist October 2024

Read

OTC Autumn 2024

In this issue of OTC Update we focus on hydration, hair care, sports injuries, fatigue, and menopause.??

Read

ADVERTISMENT

ADVERTISMENT

ADVERTISMENT

ADVERTISMENT